Mammography SPECT With Rotating Slant Hole Collimator

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2006 by Johns Hopkins University.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00328354
First received: May 18, 2006
Last updated: NA
Last verified: January 2006
History: No changes posted
  Purpose

The goal is to conduct a pilot study to determine the feasibility of the clinical use of RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical protocol.


Condition
Breast Cancer

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by Johns Hopkins University:

Estimated Enrollment: 20
Detailed Description:

The goal of this protocol is to develop and evaluate a novel SPECT imaging technique for imaging the breast using rotating multi-segment slant-hole (RMSSH) collimators. The motivation is the requirement of a low cost RMSSH collimator and a conventional LFOV camera. It is believed that RMSSH SPECT is particularly suitable for applications in breast imaging.

  Eligibility

Ages Eligible for Study:   35 Years to 80 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Women seen at Johns Hopkins Avon Division of Breast Imaging who have been diagnosed with breast cancer.

Exclusion Criteria:

  • Pregnant (or possibly pregnant)
  • Lactating
  • Unable to give consent
  • Weights over 300 pounds
  • Women who have already undergone definitive surgical treatment to their breast for breast cancer will not be eligible.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00328354

Contacts
Contact: Linda Wilkins, RT, CCRP 410-955-8216 lwilkins@jhmi.edu

Locations
United States, Maryland
Johns Hopkins Outpatient Center Not yet recruiting
Baltimore, Maryland, United States, 21287
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Benjamin Tsui, Ph.D. Johns Hopkins University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00328354     History of Changes
Other Study ID Numbers: R01 EB 0019-83 Mammography
Study First Received: May 18, 2006
Last Updated: May 18, 2006
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on September 30, 2014